Comparison of the Performance of the CRUSADE, ACUITY-HORIZONS, and ACTION Bleeding Risk Scores in STEMI Undergoing Primary PCI: Insights from a Cohort of 1391 Patients
Overview
Authors
Affiliations
Aims: To compare the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION risk models in the ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
Methods: We studied all consecutive patients with STEMI who underwent PPCI at our institution between 2006 and 2010 (n=1391). The CRUSADE, ACUITY-HORIZONS, and ACTION risk scores were calculated based on the patients' clinical characteristics. The occurrence of in-hospital major bleeding (defined as the composite of intracranial or intraocular bleeding, access site haemorrhage requiring intervention, reduction in haemoglobin ≥4 g/dl without or ≥3g/dl with overt bleeding source, reoperation for bleeding, or blood transfusion) reached 9.8%. Calibration and discrimination of the three risk models were evaluated by the Hosmer-Lemeshow test and the C-statistic, respectively. We compared the predictive accuracy of the risk scores by the DeLong non-parametric test.
Results: Calibration of the three risk scores was adequate, given the non-significant results of Hosmer-Lemeshow test for the three risk models. Discrimination of CRUSADE, ACUITY-HORIZONS, and ACTION models was good (C-statistic 0.77, 0.70, and 0.78, respectively). The CRUSADE and ACTION risk scores had a greater predictive accuracy than the ACUITY-HORIZONS risk model (z=3.89, p-value=0.0001 and z=3.51, p-value=0.0004, respectively). There was no significant difference between the CRUSADE and ACTION models (z=0.63, p=0.531).
Conclusions: The CRUSADE, ACUITY-HORIZONS, and ACTION scores are useful tools for the risk stratification of bleeding in STEMI treated by PPCI. Our findings favour the CRUSADE and ACTION risk models over the ACUITY-HORIZONS risk score.
Bilalic A, Kurir T, Borovac J, Kumric M, Supe-Domic D, Vilovic M Life (Basel). 2021; 11(8).
PMID: 34440477 PMC: 8400588. DOI: 10.3390/life11080733.
Ran P, Wei X, Lin Y, Li G, Huang J, He X Front Cardiovasc Med. 2021; 8:657817.
PMID: 34212012 PMC: 8241092. DOI: 10.3389/fcvm.2021.657817.
Brinza C, Burlacu A, Tinica G, Covic A, Macovei L Healthcare (Basel). 2021; 9(2).
PMID: 33540514 PMC: 7912805. DOI: 10.3390/healthcare9020148.
Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome.
Chan Pin Yin D, Azzahhafi J, James S J Clin Med. 2020; 9(9).
PMID: 32967247 PMC: 7565031. DOI: 10.3390/jcm9093039.
Simonsson M, Winell H, Olsson H, Szummer K, Alfredsson J, Hall M J Am Heart Assoc. 2019; 8(5):e012157.
PMID: 30803289 PMC: 6474938. DOI: 10.1161/JAHA.119.012157.